tiprankstipranks

Insulet price target raised to $334 from $320 at Raymond James

Raymond James raised the firm’s price target on Insulet to $334 from $320 and keeps an Outperform rating on the shares. The company’s 11% revenue beat in Q4 points to "clear momentum" in the U.S. OP5 launch and the firm expects this dynamic to continue, said the analyst, who also noted that initial 2023 revenue guidance came in about 4% above the consensus forecast.

Confident Investing Starts Here:

Published first on TheFly

See today’s best-performing stocks on TipRanks >>

Read More on PODD:

Disclaimer & Disclosure

Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.

Report an Issue